TrialBMC infectious diseases2022

Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial.

Carmen de la Rocha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.